Dana-Farber Cancer Institute - Foxborough — Foxborough, Massachusetts

Dana-Farber Cancer Institute - Foxborough is a clinical research site located in Foxborough, Massachusetts, United States 02035.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute - Foxborough has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Neoplasm, Neoplasm Metastasis, Breast Neoplasms.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute - Foxborough?

Dana-Farber Cancer Institute - Foxborough has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute - Foxborough conducted?

Dana-Farber Cancer Institute - Foxborough has 2 clinical trials on record, with 2 currently active. Their work covers Breast Neoplasm, Neoplasm Metastasis, Breast Neoplasms.

Is Dana-Farber Cancer Institute - Foxborough accredited by Crixeo Health?

Dana-Farber Cancer Institute - Foxborough has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute - Foxborough?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.